House votes on defense spending, FOMC action

Key Takeaways
  • House votes military spending priorities
  • Despite partisanship NDAA has passed for 63 years
  • FOMC holds steady, next meeting July 30/31

In the coming weeks I will be writing about the politics of the budget and the need to pass some, or all of the 12-appropriations bills needed to fund the US government after October 1, 2024 when the new fiscal year begins.

Last week I wrote about House consideration of the Military Construction and Veterans Affairs budget which is usually one of the less controversial and most bipartisan appropriation bills, but this year the House passed the bill on a partisan vote of 209 Yes to 197 No.  Democrats opposed the usually non-controversial legislation due to the fact that Republicans added riders, referred to in Congress as “poison pills,” that included issues ranging from abortion to the flying of the Pride Flag.

Last week a similarly bipartisan bill, the National Defense Authorization Act (NDAA), came before the House and got mired in the same controversial poison pill issues.

The bill that came out of the Appropriations Committee to the House floor stuck to the agreement on spending struck by President Biden and former Speaker Kevin McCarthy, and it represented a one-percent increase from FY 2024 and came in at $883.7B.  The bill was approved by the House Armed Services Committee on a vote of 57 to 1. Additionally, the White House sent a message to Congress supporting the bill approved by the Republican controlled Committee. However, when the bill reached the House floor Republicans added many of the same social policy riders ranging from abortion limitations to the flying of the Pride Flag on military bases. As in the Military Construction bill this led to a partisan final vote of 217 YES to 199 No.

Interestingly, early in the week as the House started to debate the NDAA, conservative Member Marjorie Taylor Greene offered an amendment to prohibit any US military money for Ukraine.  The motion was defeated on a bipartisan vote of 74 Yes to 343 No.  All 74 votes in support came from Republicans but a majority of Republicans, 138, joined all the Democrats in opposing the Ukraine cut.

The next step for the NDAA will be for the House passed bill to be sent to the Democratic controlled Senate where some of the “poison pills” will be dropped.  The NDAA is viewed as an important part of the Congressional process to keep the US military strong and prepared. It is for this reason that despite the ebb and flow of partisan politics in DC, the NDAA has been approved by Congress for the past 63 years.

As Congress usually tries to leave by the end of September in election years, they will need to develop a budget strategy in the coming weeks. If Congress can’t pass new budgets by the October 1 deadline, the practice is to maintain current spending levels by passing a Continuing Resolution (CR).  Failure to pass either budgets or a CR is what leads to a government shutdown.  The leaders of both parties will need to make a political call as to whether a shutdown impacts their chances of winning the White House and control of Congress.  Stay tuned.

FOMC

Last week the Fed, as expected, kept interest rates unchanged.  However, both the official FOMC statement and the Chair’s press conference were more hawkish than anticipated.  This was prompted by the change in the Committee Members’ forecasts from 3 rate cuts to 1.  However, I believe that it was also noteworthy that when given the chance to give a view on a potential hike, as at the April/May meeting, Chair Powell threw cold water on support for a hike.

In reviewing the minutes, this is an exert from what was posted:

“So that’s always been the thought is that, you know, since we raised rates this far, we’ve always been pointing to cuts at a certain point, not to eliminate the possibility of hikes.  But, you know, no one has that as their base case.  So – no one on the committee does.” Chair Powell press conference 06.12.2024.

The FOMC meets next July 30/31.

Disclosures (show)

This research is for the clients of FS Insight only. FSI Subscription entitles the subscriber to 1 user, research cannot be shared or redistributed. For additional information, please contact your sales representative or FS Insight at fsinsight.com.

Conflicts of Interest

This research contains the views, opinions and recommendations of FS Insight. At the time of publication of this report, FS Insight does not know of, or have reason to know of any material conflicts of interest.

General Disclosures

FS Insight is an independent research company and is not a registered investment advisor and is not acting as a broker dealer under any federal or state securities laws.

FS Insight is a member of IRC Securities’ Research Prime Services Platform. IRC Securities is a FINRA registered broker-dealer that is focused on supporting the independent research industry. Certain personnel of FS Insight (i.e. Research Analysts) are registered representatives of IRC Securities, a FINRA member firm registered as a broker-dealer with the Securities and Exchange Commission and certain state securities regulators. As registered representatives and independent contractors of IRC Securities, such personnel may receive commissions paid to or shared with IRC Securities for transactions placed by FS Insight clients directly with IRC Securities or with securities firms that may share commissions with IRC Securities in accordance with applicable SEC and FINRA requirements. IRC Securities does not distribute the research of FS Insight, which is available to select institutional clients that have engaged FS Insight.

As registered representatives of IRC Securities our analysts must follow IRC Securities’ Written Supervisory Procedures. Notable compliance policies include (1) prohibition of insider trading or the facilitation thereof, (2) maintaining client confidentiality, (3) archival of electronic communications, and (4) appropriate use of electronic communications, amongst other compliance related policies.

FS Insight does not have the same conflicts that traditional sell-side research organizations have because FS Insight (1) does not conduct any investment banking activities, and (2) does not manage any investment funds.

This communication is issued by FS Insight and/or affiliates of FS Insight. This is not a personal recommendation, nor an offer to buy or sell nor a solicitation to buy or sell any securities, investment products or other financial instruments or services. This material is distributed for general informational and educational purposes only and is not intended to constitute legal, tax, accounting or investment advice.
The statements in this document shall not be considered as an objective or independent explanation of the matters. Please note that this document (a) has not been prepared in accordance with legal requirements designed to promote the independence of investment research, and (b) is not subject to any prohibition on dealing ahead of the dissemination or publication of investment research.
Intended for recipient only and not for further distribution without the consent of FS Insight.

This research is for the clients of FS Insight only. Additional information is available upon request. Information has been obtained from sources believed to be reliable, but FS Insight does not warrant its completeness or accuracy except with respect to any disclosures relative to FS Insight and the analyst’s involvement (if any) with any of the subject companies of the research. All pricing is as of the market close for the securities discussed, unless otherwise stated. Opinions and estimates constitute our judgment as of the date of this material and are subject to change without notice. Past performance is not indicative of future results. This material is not intended as an offer or solicitation for the purchase or sale of any financial instrument. The opinions and recommendations herein do not take into account individual client circumstances, risk tolerance, objectives, or needs and are not intended as recommendations of particular securities, financial instruments or strategies. The recipient of this report must make its own independent decision regarding any securities or financial instruments mentioned herein. Except in circumstances where FS Insight expressly agrees otherwise in writing, FS Insight is not acting as a municipal advisor and the opinions or views contained herein are not intended to be, and do not constitute, advice, including within the meaning of Section 15B of the Securities Exchange Act of 1934. All research reports are disseminated and available to all clients simultaneously through electronic publication to our internal client website, fsinsight.com. Not all research content is redistributed to our clients or made available to third-party aggregators or the media. Please contact your sales representative if you would like to receive any of our research publications.

Copyright © 2025 FS Insight LLC. All rights reserved. No part of this material may be reprinted, sold or redistributed without the prior written consent of FS Insight LLC.